From the inception of the HIV pandemic, UC San Diego (UCSD) has been at the forefront of patient care efforts in San Diego county and an international leader in basic, translational, and clinical research on HIV and its associated diseases. UCSD joined the AMC in the mid-1990's as a sub-site of UCLA. With evidence of significant enrollment, active AMC participation, and strong institutional commitment, UCSD was awarded primary AMC site status in 1999. On the recommendation of the UCSD Moores Cancer Center (MCC), in March 2003, the NCI approved William Wachsman, MD,PhD, a clinician-scientist with strong credentials in retroviral and transitional genomic research, as the new UCSD AMC site PI. In 2004, Erin Reid, MD, a clinical investigator with interest in AIDS-related malignancy (ARM) became a Co-investigator for the UCSD AMC site. Robert """"""""Robin"""""""" Ryder, MD, who research is on the epidemiology of HIV, AIDS, and AIDS-related malignancy in sub-Saharan Africa, joined the UCSD AMC effort in 2008.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA121947-08
Application #
8737183
Study Section
Special Emphasis Panel (ZCA1-SRLB-D)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
8
Fiscal Year
2014
Total Cost
$166,393
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Barta, Stefan K; Joshi, Jitesh; Mounier, Nicolas et al. (2016) Central nervous system involvement in AIDS-related lymphomas. Br J Haematol 173:857-66
Gopal, Satish; Fedoriw, Yuri; Kaimila, Bongani et al. (2016) CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi. PLoS One 11:e0150445
Alvarnas, Joseph C; Le Rademacher, Jennifer; Wang, Yanli et al. (2016) Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood 128:1050-8
Epeldegui, Marta; Lee, Jeannette Y; Martínez, Anna C et al. (2016) Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial). Clin Cancer Res 22:328-36
Press, Oliver W; Li, Hongli; Schöder, Heiko et al. (2016) US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816. J Clin Oncol 34:2020-7
Hernandez, Alexandra L; Karthik, Rajiv; Sivasubramanian, Murugesan et al. (2016) Prevalence of Anal HPV Infection Among HIV-Positive Men Who Have Sex With Men in India. J Acquir Immune Defic Syndr 71:437-43
Montgomery, Nathan D; Liomba, N George; Kampani, Coxcilly et al. (2016) Accurate Real-Time Diagnosis of Lymphoproliferative Disorders in Malawi Through Clinicopathologic Teleconferences:  A Model for Pathology Services in Sub-Saharan Africa. Am J Clin Pathol 146:423-30
Willeford, Wesley G; Bachmann, Laura H (2016) Uncertainty Abounds in the World of Anal Dysplasia Screening. Sex Transm Dis 43:436-7
Bender Ignacio, Rachel A; Lee, Jeannette Y; Rudek, Michelle A et al. (2016) Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. J Acquir Immune Defic Syndr 72:52-7
Noy, Ariela; Lensing, Shelly Y; Moore, Page C et al. (2016) Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma 57:1731-4

Showing the most recent 10 out of 105 publications